Table 3. Plasma nitisinone levels (μmol/L).
Patient Number | Sample 1 | Sample 2 |
---|---|---|
2 | 2.07 | 2.08 |
101 | 1.73 | 1.55 |
103 | 2.18 | 2.91 |
106 | 2.10 | 2.23 |
107 | 2.70 | 3.02 |
110 | 2.93 | 2.53 |
112 | 2.57 | 2.50 |
113 | 2.43 | 1.97 |
118 | 1.41 | 1.34 |
120 | 1.62 | 1.72 |
122 | 2.70 | 2.30 |
123 | 2.14 | 1.47 |
126 | 2.15 | 1.99 |
128 | 3.57 | 3.05 |
129 | 1.32 | <0.07 |
132 | 2.21 | 2.52 |
135 | 2.03 | 1.87 |
136 | 2.51 | 2.74 |
137 | <0.07 | 1.60 |
124 | <0.07 | |
102 | <0.07 |
Plasma nitisinone concentrations were measured on two separate admissions in 19 nitisinone-treated patients and in 2 untreated control patients (#124 and #102). Patient #129 had the second sample measured when removed from nitisinone; patient #137 had the first sample assayed prior to starting nitisinone.